NASH patients watched, not treated, in new registry study

NCT ID NCT06123858

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 23 times

Summary

This study was designed to collect information about Chinese patients with nonalcoholic steatohepatitis (NASH) and liver scarring. Researchers aimed to describe patient characteristics, how they are diagnosed and treated in real life, and their knowledge about the disease. Over 1,100 adults aged 18-75 with NASH and moderate-to-severe fibrosis were enrolled, but no treatment was given—only observation and questionnaires.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASH WITH FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Beijing, China

  • Research Site

    Changchun, China

  • Research Site

    Chengdu, China

  • Research Site

    Fuzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Hangzhou, China

  • Research Site

    Inner Mongolia, China

  • Research Site

    Nanchang, China

  • Research Site

    Qingdao, China

  • Research Site

    Shanghai, China

  • Research Site

    Shenyang, China

  • Research Site

    Taiyuan, China

  • Research Site

    Tianjin, China

  • Research Site

    Wenzhou, China

  • Research Site

    Xi'an, China

  • Research Site

    Zhengzhou, China

Conditions

Explore the condition pages connected to this study.